Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xilio Therapeutics
Biotech
Bayer taps new chief medical officer—Chutes & Ladders
Bayer taps new chief medical officer. Cantor steps into PhRMA’s house as CEO. Moderna veteran rejoins for second act.
Darren Incorvaia
,
Marissa Russo
,
Donavyn Coffey
,
James Waldron
Oct 2, 2026 8:30am
Idorsia locks in new CEO after shakeup—Chutes & Ladders
Jul 10, 2026 8:30am
AbbVie pays Xilio $52M upfront in latest T-cell engager deal
Feb 12, 2025 8:29am
FDA's principal deputy to depart agency—Chutes & Ladders
Dec 20, 2024 8:30am
Gilead pays $43.5M for Xilio's early-phase IL-12 prospect
Mar 28, 2024 8:08am
Illumina nets new CEO—Chutes & Ladders
Sep 8, 2023 9:30am